志健金瑞,APS,新药研发,医药研发,癌症肿瘤精准治疗

CDE Approved the IND Application of the Next-generation RET inhibitor APS03118

志健金瑞,APS,新药研发,医药研发,癌症肿瘤精准治疗

CDE Accepted the IND Application of the Next-generation RET inhibitor APS03118

志健金瑞,APS,新药研发,医药研发,癌症肿瘤精准治疗

Applied Pharmaceutical Science Released the Critical Preclinical Data of Next-generation RET Inhibitor APS03118

Contact

Address

Office: Philadelphia, US

Office: Building 10-1, No.2 Jingyuan North Street, BDA, Beijing, China

Tel

+1-484-222-1342 +86-10-67860673

Mobile Mode
Copyright © 2022 All Rights Reserved Applied Pharmaceutical Science
Terms of Use

Loading...

Privacy policy

Loading...